As an industry leader in the field of antibody research and development, Creative Biolabs is committed to providing the most comprehensive antibody services for our global clients. Especially, we offer high-quality antibody development services for diagnostic applications targeting UH-RA.14 as a potential biomarker for rheumatoid arthritis.

The Role of Biomarker in Rheumatoid Arthritis

As a chronic inflammatory joint disease, rheumatoid arthritis can cause cartilage and bone damage as well as disability. Early diagnosis plays a key role in optimal therapeutic success, particularly in patients with well-characterized risk factors for poor outcomes such as high disease activity, presence of autoantibodies, and early joint damage. Biomarkers are integral to disease stratification and hence targeted therapy. They are potential in the transformation of RA management by enabling not only early diagnosis, but also assessment and prediction of disease severity. In addition, it can also be utilized in the selection of therapy, and monitoring of response to therapy.

UH-RA.14 marker- Creative Biolabs

UH-RA.14 Biomarker for Rheumatoid Arthritis Diagnosis

Recent progress in biomarker discovery for RA diagnostics results in the presence of previously identified autoantibodies to novel Hasselt University (UH) peptides in early and seronegative RA. As reported in paper, UH-RA.14 has been found as one of four novel candidate biomarkers (UH-RA.1, UH-RA.9, and UH-RA.21) that binding to one biomarker panel to identify early RA. The results suggest that the UH peptides biomarkers enable the identification of RA disease. The positive test confirms the peptide’s ability to indicate reactivity in early disease. Early disease markers including UH-RA.14 are of the utmost importance when aiming at the diagnosis of RA and the prevention of joint damage and disability.

IVD Antibody Development Services for UH-RA.14 Marker

Antibodies play pivotal roles in antibody-based immunoassays for detecting and quantifying antigens of interest in all kinds of samples such as serum, urine, tissue preparations, and so on. With our versatile IVD platform, Creative Biolabs is proud to develop novel UH-RA.14-specific antibody with high specificity and affinity. We offer a full range of IVD antibody development, antigen & antibody conjugation, and IVD kit development services to our worldwide clients. We develop antibodies that can be applied for immunoassay formats such as ELISAs, immunohistochemistry, western blot, and flow cytometry.

Creative Biolabs has accumulated abundant experience in the successful completion of many IVD-related projects. We provide services with the best quality and the most competitive prices. Our custom-built IVD antibody development services can be designed to suit the exact requirements of our clients. If you are interested in our services, contact us for more information.

Online Inquiry

*E-mail Address:
*Service & Products Interested:
Project Description:
*Verification Code:
Please input "biolabs"(case insensitive) as verification code.

Contact Us

45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356

Follow us on:
Copyright ©2011 - 2019 Creative Biolabs.